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Evolving Roles for the State,
Supra-National Bodies, and
Science
The collection, computation, and publi-
cation of health indicators was for much of
the 19
th century and the first half of the 20
th
centurythebusinessofstates—reflectingthe
etymology of the word ‘‘statistics’’ (from
Statistik, or ‘‘of the state’’). With the spread
of independence in the developing world in
the second half of the 20
th century, the
United Nations (UN) began to play a supra-
national role in the production of health
indicators to bolster weak capacity in some
developing countries. Yet, over the past five
or six decades, the expectations for the field
have expanded considerably. New con-
structs have been introduced such as
cause-specific mortality, quality of care,
and functional health status. Measurements
must often deal with the simultaneous
problemsofsynthesizingconflictingsources,
missing data, instrument bias, substantial
non-sampling error in surveys, and missing
denominators,particularlyinadministrative
data. Reflecting these complexities, in the
last 30 years, the role of the academy has
expanded from tools and methods innova-
tion to the production of comparable
measurements for key health indicators in
various countries [1] and globally [2,3].
Academic demographers have been in-
volved in the production of comparable
population measurements for nearly 50
years [4]. In the last two decades, epidemi-
ology and other health-related disciplines
have also been actively engaged in popula-
tion-level health measurement [5].
Reflecting the progressive diversification
of actors in the production of health
indicators, alternative statistics are now
available from national authorities, from
various UN agencies, and from the peer-
reviewed scientific literature [6–10]. Alterna-
tive measurements have engendered consid-
erable concern from health advocacy groups
and practitioners who rely on sound mea-
surementtoguideprograms,and fromdonor
agencies. With the 2015 target looming,
interest in reliably monitoring the progress
of countries in attaining (or not) the UN
Millennium Development Goals has intensi-
fied. In this commentary, we consider the
potential roles of different actors and high-
light four key issues that are widely debated.
Key Ingredients for Sound
Measurement and Policy
Translation
There are five distinct areas that
contribute to the ultimate production of
timely, comparable, valid, and reliable
health indicator measurements and their
translation into national policy dialogue.
Tools and Instrument Innovation
The set of tools available for data
collection and analysis is rapidly changing.
Advances in computing mean that inno-
vations such as electronic medical records
or Bayesian measurement models are now
feasible even in low-resource settings.
Most of the innovation in this area will
continue to come from the private sector
(including non-governmental organiza-
tions) and academia. The role for national
The Essay section contains opinion pieces on topics
of broad interest to a general medical audience.
Citation: Murray CJL, Lopez AD (2010) Production and Analysis of Health Indicators: The Role of
Academia. PLoS Med 7(11): e1001004. doi:10.1371/journal.pmed.1001004
Published November 30, 2010
Copyright:  2010 Murray, Lopez. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: No specific funding was received for this study; however, the Institute for Health Metrics and
Evaluation is funded by a grant from the Bill & Melinda Gates Foundation. No funding bodies had any role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: CJLM works in academia generating health indicator estimates; is the Director of the
Institute for Health Metrics and Evaluation; is a Professor of Global Health at the University of Washington; and
from 1998 to 2003 worked at the World Health Organization in Geneva, Switzerland. ADL works in academia
generating health indicator estimates; is a member of the editorial board for PLoS Medicine; is Head of the
School of Population Health and Professor of Global Health at the University of Queensland; is an Affiliate
Professor of Global Health at the Institute for Health Metrics and Evaluation; and from 1980 to 2002 worked at
the World Health Organisation in Geneva, Switzerland in a series of technical and senior managerial posts.
Abbreviations: WHO, World Health Organization
* E-mail: cjlm@u.washington.edu
Provenance: Commissioned; not externally peer reviewed. The idea for a commissioned cluster of articles on
global health estimates came from Ties Boerma and Colin Mathers at the World Health Organization.
Summary Points
N Progress on the timely, valid, reliable, and comparable measurement of health
indicators requires tools and instrument innovation; enhanced national capacity
to collect, process, archive, and share data; norms and standards for indicator
definitions and computation; multiple independent analyses of data; and
effective translation of results into policy.
N Academia and the associated process of peer-reviewed publication and open
debate should play the central role in the creation of new tools and instruments
and in the rigorous analysis of existing data to yield the best possible
assessments of key health indicators.
N The United Nations and World Bank have important roles to play in helping
countries build capacity for data collection and analysis, setting norms and
standards, and helping national decision-makers translate evidence into new
policy directions.
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Bank institutions will likely be restricted to
agenda promotion, advocacy for applica-
tion, and financing.
Capacity to Collect, Process, Archive,
and Share Data
Whether in a developed or developing
country, good health measurement re-
quires capacity in national statistical offices
and Ministries of Health to collect admin-
istrative data on case reporting, service
delivery and expenditures, and household
data through surveys and censuses. Ca-
pacity to collect, process, and archive is
both human and physical. Our view is that
academia has an important role in pro-
viding appropriate training and education;
national governments a critical role in
nurturing this capacity at national, region-
al, and local levels; donor agencies a role
in helping low-income countries finance
capacity development; and the UN system
a role in advocating for capacity develop-
ment and helping broker financial and
technical assistance. The success of the
United Nations Children’s Fund (UNI-
CEF) in raising funding for the Multiple
Indicator Cluster Surveys is a clear
example where this role has been extreme-
ly beneficial. Harnessing the capability of
scientists within countries and around the
world for data analysis requires archiving
and sharing data in a way that protects
confidentiality but stimulates innovation.
Norms and Standards for Health
Indicators
Given the rapid innovation in tools and
instruments and the expanding set of
constructs for measurement, comparable
measurement requires a periodically re-
vised set of nomenclatures, definitions, and
data standards. Non-governmental orga-
nizations or public–private partnerships
have been effective in promulgating some
standards such as Health Level Seven
(HL7) or Systematized Nomenclature of
Medicine—Clinical Terms (SNOMED
CT). Nevertheless, there is a key role for
supra-national bodies such as the World
Health Organization (WHO), given its
governance mandate, in setting universal
standards. WHO has successfully steward-
ed the International Classification of
Diseases for over 60 years and should
continue to be a leader in setting a wide
range of health norms and standards.
Analysis of Data
It is the nature ofhealthdata that estima-
tion of health indicators often requires
more than data processing. Measurements
from differentsources may conflict,data for
some localities or years may be missing,
survey instruments may be biased, admin-
istrative data systems may exclude groups
such as the poor, and so on. After
processing, data need to be analyzed with
the best available scientific methods. Anal-
ysis is required both for the production of
comparable, valid, and reliable measure-
mentsaswellasforthemore difficulttaskof
interpretation or causal inference. National
statistical authorities, academics, and UN
institutions all undertake data analysis.
Given the myriad data challenges outlined
above, there is considerable scope for
reasonable scientists to disagree on the
interpretation of data, whether for descrip-
tive or causal reasons. Given that the task is
fundamentally a scientific challenge, we
believe that it should primarily be the role
of independent scientists in academic
institutions, independent of the agencies
or programs that collect or collate the data.
Additionally, the discipline of peer review,
although imperfect, brings a transparency
and objectivity to the analysis of data.
Policy Translation
Sound measurement of health indica-
tors should serve as input to a more
informed national health policy debate.
The gap between science and policy
formulation can be large. Through their
trusted relationship with governments, UN
and World Bank institutions can play a key
role in policy translation. In some coun-
tries, independent think tanks, academics,
and national academies of science can also
play a key role in the translation of
empirical findings into policy options.
Four Issues in the Debate
1. Estimates or Country Reporting?
The debate over the best measurements
for child and maternal mortality is some-
times framed as a debate on estimates
versus country reports [11]. Proponents for
the latterappear to believe that‘‘estimates’’
are inherently undesirable and fraught
with uncertainty, while country reports
are inherently valid, reflecting the reality
on the ground. This debate masks two
different issues. First, in 2010, all sound
measurements are insomeway‘‘estimates’’
in that appropriate statistical methods have
been applied to the primary processed data
to yield a measurement. For example, in a
high-income country like the United
States, measurement of the maternal
mortality rate must deal with misclassifica-
tion of maternal deaths to other causes,
census counts need to be adjusted for
under-enumeration, and smoking rates
from the Behavioral Risk Factor Surveil-
lance System must be adjusted for nonre-
sponse bias by age, sex, and race.
The second issue is one of political
provenance. For some health indicators, it
is awkward for some UN agencies to
disagree with national authorities. This
debate is code speak for avoiding disagree-
ing with Ministries of Health or other
government authorities by publishing gov-
ernment figures regardless of the quality of
data or the rigor of the analysis applied to
the data. The real issue is whether we
want science-based measurement or polit-
ical measurement. The world needs the
former; there really is no role for the latter.
2. Multiple Figures Will Confuse
Donor Country Agencies and
Legislators and Decision-Makers in
Low-Income Countries
Some advocacy groups believe that
public debate over the magnitude and
trend of key health indicators can under-
mine support for health programs among
donors and will confuse leaders in devel-
oping countries. For example, in the
maternal mortality debate, one advocate
argued that scientists should be locked in a
room until they agree on one set of
numbers. We believe the drive to artificial
consensus is fundamentally misguided.
Health leaders in developing countries
have the sophistication and experience to
understand that measurement is challeng-
ing and that there will be uncertainty in
the assessment of levels and trends. The
recent unfolding of ‘‘Climategate’’ illus-
trates how forced consensus can under-
mine public confidence in an important
agenda [12]. Rather than forcing a false
consensus among scientists, we believe that
it is the responsibility of the scientific
community to encourage robust public
discourse on critical health indicators; such
dialogue will lead to both a better
understanding of the health challenges
nations face and an appreciation of the
realities of uncertainty in measurement. It
ought also to accelerate efforts in countries
to improve critical health information
systems.
3. The UN as Player and Referee in
the Scientific Arena
Some excellent scientists work for the
UN and its technical agencies. In their role
as scientists they sometimes analyze data
and produce measurements for health
indicators. Occasionally, this work is
subject to the normal process of peer
review, but more often it is published
under the imprimatur of the UN. The
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communities need the UN, especially
WHO, to assume the leading role in
setting norms and standards for indicators.
It is difficult to see how the UN can be the
trusted developer of norms and standards
and a respected neutral broker when it is
also trying to compete in the health
measurement arena [13]. Inevitably, this
creates a conflict of interest, often leading
to UN agencies promoting their own
estimates using their imprimatur, depriv-
ing countries and other users of the
advantages of scientific exchange and
debate. In our view, these efforts progres-
sively undermine the UN’s capacity to set
standards in the long term. The UN can,
and we believe should, use their effective
relationships with governments to promote
the translation of scientific findings into
more effective national policy formulation.
Can one clearly distinguish data analysis
to produce timely, valid, and reliable
health indicator measurements from anal-
yses to support policy translation in a given
country? One useful guide to the dividing
line is that when there is a need for
innovation in methods or application of
methods, the role for academia is more
compelling. Timely application of existing
analytical tools to inform policy as part of
an ongoing institutional dialogue may be
more effectively delivered by the UN
institutions, national think tanks, or con-
sulting organizations.
4. Good Practice Guidelines
The rise of low-cost computational
power has already had a far-reaching
impact on the analysis of data to produce
comparable, valid, and reliable measure-
ments of health indicators. An impressive
array of computationally intensive methods
has now been applied in health [14], with
further innovation and methodological
advances on the horizon. Given the
methods innovation and the increasingly
diverse set of scientists drawn to the
challenge of health measurement, it is
becoming increasingly important to create
a set of guidelines for health indicator
studies. These guidelines should cover key
areas such as the definition of a systematic
analysis using all available data, require-
ments for transparency on data and
methods, necessary tests of predictive
validity, calculation of uncertainty intervals
based on sound scientific principles, and
attempts to adjust data for known bias.
We believe that the diversification of
actors involved in health indicator mea-
surement over the last 30 years or so has
been tremendously positive. The expand-
ing role of academics in health measure-
ment, whether at the national or global
level, is helping to shift practice away from
a political state-based model of health
measurement to a science-based model.
As analytical capacity in academic institu-
tions in developing countries continues to
expand, more national and regional com-
parative studies will emerge from scientists
at these institutions. This is a most welcome
development, and efforts to strengthen
analytical capacity must remain a priority
[15]. There are important roles for states,
inter-governmental organizations, donor
agencies, the private sector, and academia.
By harnessing the extraordinary power of
innovation in the scientific world, decision-
makers in all countries will benefit from
more timely, comparable, valid, and reli-
able measurements of the health constructs
that they seek to influence.
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